コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 es (18 upper endoscopies, 7 colonoscopies, 2 endoscopic retrograde cholangiopancreatographies).
2 endoscopies, 1109 lower endoscopies, and 58 endoscopic retrograde cholangiopancreatographies).
3 stological analysis from tissue extracted by endoscopic retrograde cholangiopancreatography.
4 here is increasing pediatric experience with endoscopic retrograde cholangiopancreatography.
5 ings correlated with those at helical CT and endoscopic retrograde cholangiopancreatography.
6 elial recognition of T cells obtained during endoscopic retrograde cholangiopancreatography.
7 preliminary testing and tissue sampling with endoscopic retrograde cholangiopancreatography.
8 be convened to decide on the advisability of endoscopic retrograde cholangiopancreatography.
9 ), uSEMS (n = 75), or pcSEMS (n = 71) during endoscopic retrograde cholangiopancreatography.
10 quiring expertise in both endosonography and endoscopic retrograde cholangiopancreatography.
11 liary anastomotic stricture was confirmed by endoscopic retrograde cholangiopancreatography.
12 who failed to have a biliary stent placed by endoscopic retrograde cholangiopancreatography.
13 c techniques for attaining biliary access at endoscopic retrograde cholangiopancreatography.
14 lth (NIH) State-of-the-Science Conference on endoscopic retrograde cholangiopancreatography.
15 ry sclerosing cholangitis in comparison with endoscopic retrograde cholangiopancreatography.
16 olving areas include chemoprevention of post-endoscopic retrograde cholangiopancreatography acute pan
18 rred for elective direct cholangiography (45 endoscopic retrograde cholangiopancreatography and 1 per
20 Pancreatic ductal anatomy was defined using endoscopic retrograde cholangiopancreatography and categ
22 ts have poor correlation with the results of endoscopic retrograde cholangiopancreatography and the s
23 eatitis following abdominal trauma, surgery, endoscopic retrograde cholangiopancreatography, and gall
24 s included angiography, computed tomography, endoscopic retrograde cholangiopancreatography, and magn
25 n of patients at risk for pancreatitis after endoscopic retrograde cholangiopancreatography, and refi
26 es for use in endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography are just
27 of the current investigations in therapeutic endoscopic retrograde cholangiopancreatography as well a
29 mphasizes the broadening therapeutic role of endoscopic retrograde cholangiopancreatography as well a
30 ples from 50 patients undergoing therapeutic endoscopic retrograde cholangiopancreatography at univer
31 Endoscopic retrograde cholangiopancreatography brushings
32 ooled data demonstrate that balloon-assisted endoscopic retrograde cholangiopancreatography can achie
33 at rectal diclofenac given immediately after endoscopic retrograde cholangiopancreatography can reduc
35 f using abdominal computed tomography scans, endoscopic retrograde cholangiopancreatography, carcinoe
36 Endoscopic retrograde cholangiopancreatography confirmed
37 Pediatric endoscopic retrograde cholangiopancreatography continues
40 ted from the bile of PSC patients undergoing endoscopic retrograde cholangiopancreatography earlier i
41 omies (VLCs), 2 open cholecystectomies and 4 endoscopic retrograde cholangiopancreatography/endoscopi
44 ictures and leaks are typically managed with endoscopic retrograde cholangiopancreatography (ERCP) an
46 tic use at 1 year were increased by previous endoscopic retrograde cholangiopancreatography (ERCP) an
49 t pancreatitis who were scheduled to undergo endoscopic retrograde cholangiopancreatography (ERCP) be
52 ic probe compatible with cholangioscopes and endoscopic retrograde cholangiopancreatography (ERCP) ca
54 eatic tissues to radiocontrast agents during endoscopic retrograde cholangiopancreatography (ERCP) ca
56 This method of biopsy and others, such as endoscopic retrograde cholangiopancreatography (ERCP) cy
57 ndings with histopathology/surgical findings/Endoscopic Retrograde CholangioPancreatography (ERCP) fi
59 Endoscopic ultrasonography (EUS) may replace endoscopic retrograde cholangiopancreatography (ERCP) fo
61 The ideal type of stent utilized at index endoscopic retrograde cholangiopancreatography (ERCP) in
62 is recommended to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in
63 This study presents the experience of using endoscopic retrograde cholangiopancreatography (ERCP) in
64 loon-assisted enteroscopy allows therapeutic endoscopic retrograde cholangiopancreatography (ERCP) in
65 frequency and severity of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in
67 population-level data on the performance of endoscopic retrograde cholangiopancreatography (ERCP) in
73 struction can be performed endoscopically by endoscopic retrograde cholangiopancreatography (ERCP) or
74 or both may benefit from ductal drainage via endoscopic retrograde cholangiopancreatography (ERCP) or
75 creatic ductal anatomy evaluated by means of endoscopic retrograde cholangiopancreatography (ERCP) or
76 ce of periampullary diverticulum (PAD) among endoscopic retrograde cholangiopancreatography (ERCP) pa
78 smitted by contaminated duodenoscopes during endoscopic retrograde cholangiopancreatography (ERCP) pr
79 Secondary outcomes were time to surgery, endoscopic retrograde cholangiopancreatography (ERCP) ra
80 ned in 34 patients with PSC established with endoscopic retrograde cholangiopancreatography (ERCP) we
81 an episode of choledocholithiasis requiring endoscopic retrograde cholangiopancreatography (ERCP) wi
84 ndoscopic ultrasonography (US), 21 patients; endoscopic retrograde cholangiopancreatography (ERCP), 1
85 ances of periduodenal perforation related to endoscopic retrograde cholangiopancreatography (ERCP), a
86 apy, early enteral feeding, judicious use of endoscopic retrograde cholangiopancreatography (ERCP), a
87 ancreatitis in high-risk patients undergoing endoscopic retrograde cholangiopancreatography (ERCP), b
88 n which MRCP was evaluated and compared with endoscopic retrograde cholangiopancreatography (ERCP), c
89 xperience an unplanned hospitalization after endoscopic retrograde cholangiopancreatography (ERCP), l
90 be readily translatable to humans through an endoscopic retrograde cholangiopancreatography (ERCP), m
91 iculum (PAD) is an incidental finding during endoscopic retrograde cholangiopancreatography (ERCP), o
93 itis remains the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), r
95 asis is controversial, the 2-stage approach [endoscopic retrograde cholangiopancreatography (ERCP), s
99 creases the occurrence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).
100 scribed comparable accuracy when compared to endoscopic retrograde cholangiopancreatography (ERCP).
101 ict CBD stones and the need for preoperative endoscopic retrograde cholangiopancreatography (ERCP).
102 percutaneous, or endoscopic) have undergone endoscopic retrograde cholangiopancreatography (ERCP).
103 mary measured outcome was pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).
104 criteria for choledocholithiasis to receive endoscopic retrograde cholangiopancreatography (ERCP).
105 creases the occurrence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).
106 hacin reduces the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).
107 is the most common major complication after endoscopic retrograde cholangiopancreatography (ERCP).
108 n complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP).
109 of CBD stones before initiating therapeutic endoscopic retrograde cholangiopancreatography (ERCP).
110 ntial components of most current therapeutic endoscopic retrograde cholangiopancreatography (ERCP).
111 y reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP).
112 creening tool in all PSC patients undergoing endoscopic retrograde cholangiopancreatography (ERCP).
113 outcomes included crossover rate, numbers of endoscopic retrograde cholangiopancreatography (ERCPs) a
114 actable pain, and all patients had undergone endoscopic retrograde cholangiopancreatography for attem
115 rush samples from 272 patients who underwent endoscopic retrograde cholangiopancreatography for evalu
116 ndoscopic ultrasound are destined to replace endoscopic retrograde cholangiopancreatography for many
117 ens from 233 consecutive patients undergoing endoscopic retrograde cholangiopancreatography for pancr
118 ifically, we focus on the latest findings on endoscopic retrograde cholangiopancreatography for the e
119 e Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks
121 tions associated with duodenoscopes used for endoscopic retrograde cholangiopancreatography have high
122 c ultrasonography (EUS) correlates well with endoscopic retrograde cholangiopancreatography in modera
123 gallbladder stenting and the performance of endoscopic retrograde cholangiopancreatography in patien
124 citation, initiating early feeding, avoiding endoscopic retrograde cholangiopancreatography in the ab
125 (brushings and/or endobiliary biopsy) during endoscopic retrograde cholangiopancreatography in the ab
127 well as the finding that diclofenac prevents endoscopic retrograde cholangiopancreatography-induced p
130 f TIPS and is likely to be overlooked unless endoscopic retrograde cholangiopancreatography is perfor
132 Results were correlated with endoscopic retrograde cholangiopancreatography, laborato
134 Endoscopic retrograde cholangiopancreatography mitigates
135 tomography, magnetic resonance (MR) imaging, endoscopic retrograde cholangiopancreatography, MR chola
136 tors in AC, evaluate the effect of timing of endoscopic retrograde cholangiopancreatography on clinic
137 [95% CI, 1.08-1.85]; P = .01), preoperative endoscopic retrograde cholangiopancreatography (OR, 2.07
138 se of ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreati
139 gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreati
140 Enteroscopy-based endoscopic retrograde cholangiopancreatography, percutan
141 d laparoscopically in experienced hands, and endoscopic retrograde cholangiopancreatography plays a d
143 16 patients over the course of 40 weeks via endoscopic retrograde cholangiopancreatography procedure
144 le metallic stents (cSEMS) may require fewer endoscopic retrograde cholangiopancreatography procedure
145 oscopic ultrasound examinations, and 169,500 endoscopic retrograde cholangiopancreatography procedure
146 asonography allowed for tissue analysis, and endoscopic retrograde cholangiopancreatography provided
147 ors such as toxins (alcohol), gallstones, or endoscopic retrograde cholangiopancreatography result in
151 ained in patients who underwent preoperative endoscopic retrograde cholangiopancreatography since the
155 ed by elevated amylase or lipase levels, and endoscopic retrograde cholangiopancreatography was the m
156 s has replaced the diagnostic utilization of endoscopic retrograde cholangiopancreatography which is
157 ent was transferred to our hospital where an endoscopic retrograde cholangiopancreatography with bili
158 loped cholangitis, necessitating an emergent endoscopic retrograde cholangiopancreatography with bili
159 tients with choledocholithiasis treated with endoscopic retrograde cholangiopancreatography with lapa
161 n, bile leak, retained stones, postoperative endoscopic retrograde cholangiopancreatography, wound in